Universidad Complutense de Madrid
E-Prints Complutense

Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy



Último año

Backer, Lynn de y Cerrada, Alejandro y Pérez Gil, Jesús y Smedt, Stefaan C. de y Raemdonck, Koen (2015) Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy. Journal of Controlled Release, 220 . pp. 642-650. ISSN 0168-3659

[img] PDF
Restringido a Sólo personal autorizado del repositorio


URL Oficial: https://doi.org/10.1016/j.jconrel.2015.09.004


Many pathologies of the respiratory tract are inadequately treated with existing small molecule-based therapies. The emergence of RNA interference (RNAi) enables the post-transcriptional silencing of key molecular disease factors that cannot readily be targeted with conventional small molecule drugs. Pulmonary administration of RNAi effectors, such as small interfering RNA (siRNA), allows direct delivery into the lung tissue, hence reducing systemic exposure. Unfortunately, the clinical translation of RNAi is severely hampered by inefficient delivery of siRNA therapeutics towards the cytoplasm of the target cells. In order to have a better control of the siRNA delivery process, both extra- and intracellular, siRNAs are typically formulated in nanosized delivery vehicles (nanoparticles, NPs). In the lower airways, which are the targeted sites of action for multiple pulmonary disorders, these siRNA-loaded NPs will encounter the pulmonary surfactant (PS) layer, covering the entire alveolar surface. The interaction between the instilled siRNA-loaded NPs and the PS at this nano-bio interface results in the adsorption of PS components onto the surface of the NPs. The formation of this so-called biomolecular corona conceals the original NP surface and will therefore profoundly determine the biological efficacy of the NP. Though this interplay has initially been regarded as a barrier towards efficient siRNA delivery to the respiratory target cell, recent reports have illustrated that the interaction with PS might also be beneficial for local pulmonary siRNA delivery.

Tipo de documento:Artículo
Palabras clave:Lung; Nano-bio interface; Nanoparticle; Pulmonary delivery; Pulmonary surfactant; SiRNA
Materias:Ciencias Biomédicas > Biología
Ciencias Biomédicas > Biología > Biología molecular
Ciencias Biomédicas > Biología > Biotecnología
Ciencias Biomédicas > Biología > Bioquímica
Código ID:43153
Depositado:06 Jun 2017 16:17
Última Modificación:07 Jun 2017 07:28

Descargas en el último año

Sólo personal del repositorio: página de control del artículo